See also this year's filing and all EDGAR filings for this company.
PDF Report 0001442836_2018_Mersana_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001442836, Mersana Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 117,543,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,319,000 |
| 3 | remainder_Assets | 10,853,000 |
| 4 | LiabilitiesCurrent | 31,881,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 10,462,000 |
| 9 | ResearchAndDevelopmentExpense | 46,700,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 17,545,000 |
| 12 | remainder_NetIncome | 910,000 |
| 13 | remainder_ComprehensiveNetIncome | -149,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 130,715,000 |
| 1 | Liabilities | 31,881,000 |
| 2 | Expenses | 57,162,000 |
| 3 | Revenues | 17,545,000 |
| 4 | StockholdersEquity | 98,834,000 |
| 5 | NetIncome | -38,707,000 |
| 6 | ComprehensiveNetIncome | -38,781,500 |
| 7 | BaseVar | 119,181,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.17 |
| 9 | EconomicCapitalRatio | 3.14 |